Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum
Background: Large-scale neuronal network breakdown underlies memory impairment in Alzheimer’s disease (AD). However, the differential trajectories of the relationships between network organisation and memory across pathology and cognitive stages in AD remain elusive. We determined whether and how th...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/164534 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-164534 |
---|---|
record_format |
dspace |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Medicine Alzheimer Disease Brain Metabolism |
spellingShingle |
Science::Medicine Alzheimer Disease Brain Metabolism Ng, Kok Pin Qian, Xing Ng, Kwun Kei Ji, Fang Rosa-Neto, Pedro Gauthier, Serge Kandiah, Nagaendran Zhou, Helen Juan Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
description |
Background: Large-scale neuronal network breakdown underlies memory impairment in Alzheimer’s disease (AD). However, the differential trajectories of the relationships between network organisation and memory across pathology and cognitive stages in AD remain elusive. We determined whether and how the influences of individual-level structural and metabolic covariance network integrity on memory varied with amyloid pathology across clinical stages without assuming a constant relationship. Methods: Seven hundred and eight participants from the Alzheimer’s Disease Neuroimaging Initiative were studied. Individual-level structural and metabolic covariance scores in higher-level cognitive and hippocampal networks were derived from magnetic resonance imaging and [18F] fluorodeoxyglucose positron emission tomography using seed-based partial least square analyses. The non-linear associations between network scores and memory across cognitive stages in each pathology group were examined using sparse varying coefficient modelling. Results: We showed that the associations of memory with structural and metabolic networks in the hippocampal and default mode regions exhibited pathology-dependent differential trajectories across cognitive stages using sparse varying coefficient modelling. In amyloid pathology group, there was an early influence of hippocampal structural network deterioration on memory impairment in the preclinical stage, and a biphasic influence of the angular gyrus-seeded default mode metabolic network on memory in both preclinical and dementia stages. In non-amyloid pathology groups, in contrast, the trajectory of the hippocampus-memory association was opposite and weaker overall, while no metabolism covariance networks were related to memory. Key findings were replicated in a larger cohort of 1280 participants. Conclusions: Our findings highlight potential windows of early intervention targeting network breakdown at the preclinical AD stage. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Ng, Kok Pin Qian, Xing Ng, Kwun Kei Ji, Fang Rosa-Neto, Pedro Gauthier, Serge Kandiah, Nagaendran Zhou, Helen Juan |
format |
Article |
author |
Ng, Kok Pin Qian, Xing Ng, Kwun Kei Ji, Fang Rosa-Neto, Pedro Gauthier, Serge Kandiah, Nagaendran Zhou, Helen Juan |
author_sort |
Ng, Kok Pin |
title |
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
title_short |
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
title_full |
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
title_fullStr |
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
title_full_unstemmed |
Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum |
title_sort |
stage-dependent differential influence of metabolic and structural networks on memory across alzheimer's disease continuum |
publishDate |
2023 |
url |
https://hdl.handle.net/10356/164534 |
_version_ |
1759856755964116992 |
spelling |
sg-ntu-dr.10356-1645342023-03-05T16:54:22Z Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum Ng, Kok Pin Qian, Xing Ng, Kwun Kei Ji, Fang Rosa-Neto, Pedro Gauthier, Serge Kandiah, Nagaendran Zhou, Helen Juan Lee Kong Chian School of Medicine (LKCMedicine) National Neuroscience Institute Duke-NUS Medical School Science::Medicine Alzheimer Disease Brain Metabolism Background: Large-scale neuronal network breakdown underlies memory impairment in Alzheimer’s disease (AD). However, the differential trajectories of the relationships between network organisation and memory across pathology and cognitive stages in AD remain elusive. We determined whether and how the influences of individual-level structural and metabolic covariance network integrity on memory varied with amyloid pathology across clinical stages without assuming a constant relationship. Methods: Seven hundred and eight participants from the Alzheimer’s Disease Neuroimaging Initiative were studied. Individual-level structural and metabolic covariance scores in higher-level cognitive and hippocampal networks were derived from magnetic resonance imaging and [18F] fluorodeoxyglucose positron emission tomography using seed-based partial least square analyses. The non-linear associations between network scores and memory across cognitive stages in each pathology group were examined using sparse varying coefficient modelling. Results: We showed that the associations of memory with structural and metabolic networks in the hippocampal and default mode regions exhibited pathology-dependent differential trajectories across cognitive stages using sparse varying coefficient modelling. In amyloid pathology group, there was an early influence of hippocampal structural network deterioration on memory impairment in the preclinical stage, and a biphasic influence of the angular gyrus-seeded default mode metabolic network on memory in both preclinical and dementia stages. In non-amyloid pathology groups, in contrast, the trajectory of the hippocampus-memory association was opposite and weaker overall, while no metabolism covariance networks were related to memory. Key findings were replicated in a larger cohort of 1280 participants. Conclusions: Our findings highlight potential windows of early intervention targeting network breakdown at the preclinical AD stage. National Medical Research Council (NMRC) Published version Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.Inc; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.Inc; Cogstate; Eisai Inc.Inc; Elan Pharmaceuticals, Inc.Inc; Eli Lilly and Company; EuroImmun; F Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.Inc; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.Inc; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.Inc; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (https://www. fnih.org/). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. We also acknowledge the funding support from Yong Loo Lin School of Medicine, National University of Singapore (JHZ), the Duke-NUS/Khoo Bridge Funding Award (JHZ, KBrFA/2019–0020), NMRC Open Fund Large Collaborative Grant (JHZ, OFLCG09May0035) and NMRC New Investigator Grant (KPN, MOH-CNIG18may-0003). 2023-01-31T05:01:53Z 2023-01-31T05:01:53Z 2022 Journal Article Ng, K. P., Qian, X., Ng, K. K., Ji, F., Rosa-Neto, P., Gauthier, S., Kandiah, N. & Zhou, H. J. (2022). Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer's disease continuum. ELife, 11, e77745-. https://dx.doi.org/10.7554/eLife.77745 2050-084X https://hdl.handle.net/10356/164534 10.7554/eLife.77745 36053063 2-s2.0-85138446660 11 e77745 en MOHCNIG18may-0003 eLife © Ng, Qian et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. application/pdf |